Local complement inhibition by selective precision-targeted therapies
{{output}}
Excessive complement activation represents a major pathogenic mechanism for a range of serious human diseases. Complement-inhibitory therapeutics have been approved for a number of rare and ultra-rare conditions, with several others in clinical development. Th... ...
